1. Home
  2. VYX vs PCRX Comparison

VYX vs PCRX Comparison

Compare VYX & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.52

Market Cap

980.9M

Sector

N/A

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
PCRX
Founded
1881
2006
Country
United States
United States
Employees
13500
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.9M
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
VYX
PCRX
Price
$6.52
$23.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
$13.67
$30.25
AVG Volume (30 Days)
2.2M
516.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
N/A
$8.54
P/E Ratio
N/A
$336.29
Revenue Growth
N/A
26.04
52 Week Low
$6.02
$18.80
52 Week High
$14.67
$27.64

Technical Indicators

Market Signals
Indicator
VYX
PCRX
Relative Strength Index (RSI) 41.88 49.85
Support Level $6.21 $22.13
Resistance Level $7.26 $24.20
Average True Range (ATR) 0.42 1.02
MACD -0.12 -0.06
Stochastic Oscillator 12.78 42.93

Price Performance

Historical Comparison
VYX
PCRX

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: